AMAM
Ambrx Biopharma Inc
AMAM
AMAM
Delisted
AMAM was delisted on the 6th of March, 2024.
42 hedge funds and large institutions have $789M invested in Ambrx Biopharma Inc in 2023 Q2 according to their latest regulatory filings, with 18 funds opening new positions, 13 increasing their positions, 8 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
24% more call options, than puts
Call options by funds: $4.87M | Put options by funds: $3.92M
0% more funds holding in top 10
Funds holding in top 10: 4 → 4 (0)
Holders
42
Holding in Top 10
4
Calls
$4.87M
Puts
$3.92M
Top Buyers
| 1 | +$88.6M | |
| 2 | +$31.4M | |
| 3 | +$27.2M | |
| 4 |
CAM
Cormorant Asset Management
Boston,
Massachusetts
|
+$18.4M |
| 5 |
Holocene Advisors
New York
|
+$15M |
Top Sellers
| 1 | -$26.8M | |
| 2 | -$13.4M | |
| 3 | -$2.22M | |
| 4 |
Simplex Trading
Chicago,
Illinois
|
-$1.87M |
| 5 |
Nomura Holdings
Tokyo,
Japan
|
-$511K |